AVIR
Price:
$3.35
Market Cap:
$282.81M
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 for the treatment of hepatitis C virous (HCV); and AT-281, a pharmaceutically acc...[Read more]
Industry
Biotechnology
IPO Date
2020-10-30
Stock Exchange
NASDAQ
Ticker
AVIR
According to Atea Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -33.24%. This represents a change of 293.63% compared to the average of -8.45% of the last 4 quarters.
The mean historical ROE of Atea Pharmaceuticals, Inc. over the last ten years is 4.12%. The current -33.24% ROE has changed -906.85% with respect to the historical average. Over the past ten years (40 quarters), AVIR's ROE was at its highest in in the September 2020 quarter at 23.03%. The ROE was at its lowest in in the March 2020 quarter at -25.33%.
Average
4.12%
Median
7.54%
Minimum
-24.49%
Maximum
27.15%
Discovering the peaks and valleys of Atea Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 35.33%
Maximum Annual ROE = 27.15%
Minimum Annual Increase = -960.59%
Minimum Annual ROE = -24.49%
Year | ROE | Change |
---|---|---|
2023 | -24.49% | 35.33% |
2022 | -18.09% | -206.02% |
2021 | 17.07% | -960.59% |
2020 | -1.98% | -107.30% |
2019 | 27.15% | 8.33% |
The current ROE of Atea Pharmaceuticals, Inc. (AVIR) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-8.51%
5-year avg
-0.07%
10-year avg
4.12%
Atea Pharmaceuticals, Inc.’s ROE is greater than Immix Biopharma, Inc. (-86.48%), less than CNS Pharmaceuticals, Inc. (428.91%), greater than Hepion Pharmaceuticals, Inc. (-328.66%), greater than Freeline Therapeutics Holdings plc (-110.68%), less than AVROBIO, Inc. (29.68%), greater than Enveric Biosciences, Inc. (-234.16%), greater than CohBar, Inc. (-58.44%), greater than Elevation Oncology, Inc. (-57.97%), less than Ocean Biomedical, Inc. (64.85%), less than eFFECTOR Therapeutics, Inc. (2.18%),
Company | ROE | Market cap |
---|---|---|
-86.48% | $43.37M | |
428.91% | $3.98M | |
-328.66% | $3.68M | |
-110.68% | $28.28M | |
29.68% | $5.24M | |
-234.16% | $4.14M | |
-58.44% | $1.42M | |
-57.97% | $30.89M | |
64.85% | $31.18M | |
2.18% | $1.88K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atea Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Atea Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Atea Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Atea Pharmaceuticals, Inc. (AVIR)?
What is the highest ROE for Atea Pharmaceuticals, Inc. (AVIR)?
What is the 3-year average ROE for Atea Pharmaceuticals, Inc. (AVIR)?
What is the 5-year average ROE for Atea Pharmaceuticals, Inc. (AVIR)?
How does the current ROE for Atea Pharmaceuticals, Inc. (AVIR) compare to its historical average?